ERBB2 and gastric cancer: There was an opposite OS trend in HER2-negative patients (Supplemental Figure S6B), while all gastric cancer patients combined showed a significant positive correlation between high mean JAM-A, HER2 and FOXA1 expression and poor OS (Supplemental Figure S6C) similar to that in the HER2-positive population alone.